课题基金 / 基金详情

Roles of activation of antigen specific cytoxic T cells against micro bial infections.

Roles of activation of antigen specific cytoxic T cells against micro bial infections.
抗原特异性细胞毒性 T 细胞激活对抗微生物感染的作用。
批准号:
09670293
负责人:
OKUDA Kenji
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

OKUDA Kenji的其他基金

相似基金

相关文献

中文摘要
翻译
已经在几种动物模型中报道了使用pLasmid DNA编码的微生物抗原来提高针对病原体的体液和细胞免疫应答的功效,并且这种方法被称为DNA疫苗接种。在艾滋病疫苗开发领域,我们和其他人已经成功地通过DNA疫苗接种诱导了HIV-1特异性免疫应答。与传统的蛋白质疫苗相比,DNA疫苗在稳定性、易于生产和诱导细胞介导的免疫等方面具有潜在的优势。为了获得更强的免疫应答,人们尝试了一些方法,如利用基因枪系统的粒子轰击,或应用局部麻醉剂促进DNA进入肌肉细胞,并取得了实质性的成功。在本系列的一系列研究中,我们证明了1)DNA疫苗可以诱导高水平的Th 1免疫应答,2)并且这些应答通过添加IL-12表达质粒而增强。3)GM-CSF表达质粒增强Th 2型免疫应答。4)鼻内给药(i.n.)DNA疫苗比肌肉注射疫苗诱导的Th 2免疫应答水平更高。5)DNA疫苗可诱导小鼠产生高水平的粘膜免疫。本系列研究表明,DNA疫苗能诱导较好的抗原特异性免疫应答。
英文摘要
The efficacy of using pLasmid DNA-encoding microbial antigens to by us raise humoral and cellular immune responses against pathogens has been reported in several animal models, and this method is referred to as DNA vaccination. In the field of AIDS vaccine development, others and we have succeeded in inducing HIV-1-specific immune responses by DNA vaccination. DNA vaccination offers potential advantages over traditional protein-based vaccines in areas such as stability, ease of production, and induction of cell-mediated immunity. To obtain stronger responses, approaches such as the use of particle bombardment by means of a gene gun system, or application of local anesthetics to facilitate DNA entry into muscle cells have been attempted and have met with substantial success.In the present series of series of studies we have demonstrated that 1) DNA vaccine can induce a high level of Th1 immune responses, 2) and these responses are enhanced by the addition of IL-12 expression plasmids. 3) GM-CSF expression plasmids enhanced Th2 type immune responses. 4) Intranasal administration (i.n.) of DNA vaccine enhance induced higher levels of Th2 immune responses than intramuscular immunization. 5) In administration of DNA vaccine induced high levels of mucosal immunities. In this series of our studies revealed that DNA vaccine could induce a good level of antigen specific immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tsuji, T.: "HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine." Immunol.90・1. 1-6 (1997)
Tsuji, T.:“通过 TCA3 表达质粒与 DNA 疫苗共接种来增强 HIV-1 特异性细胞介导的免疫。”Immunol.90·1(1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Asakura, Y.: "Induction of HIV-1 specific mucosal immune responses by DNA vaccination." Scand.J.Immunol.46・4. 326-330 (1997)
Asakura, Y.:“通过 DNA 疫苗接种诱导 HIV-1 特异性粘膜免疫反应。” Scand.J.Immunol.46·4 (1997)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sasaki, S.: "Adjuvant effect of ubenimex on the responses induced by DNA vaccine for human immunodeficiency virus type-1." Clin.Exp.Immunol.111. 30-36 (1998)
Sasaki, S.:“ubenimex 对人类免疫缺陷病毒 1 型 DNA 疫苗诱导反应的佐剂作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 102 条
    Developmental research of new generation DNA vaccine against microorganism using synthesized DNA
    • 批准号:
      15390145
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.86万
    • 财政年份:
      2003
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    Enhancement of protection against various microbial infection by the modification of dominance of Thl or Th2 immune responses
    • 批准号:
      11470070
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.79万
    • 财政年份:
      1999
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    Study on the DNA immunization against microbial infection
    • 批准号:
      10044308
    • 项目类别:
      Grant-in-Aid for Scientific Research (C).
    • 资助金额:
      $1.73万
    • 财政年份:
      1998
    • 负责人:
      OKUDA Kenji
    • 依托单位:
    国内基金
    海外基金
    基于NASBA-侧向层析联用的HIV-1 RNA检测方法构建及其扩增-识别耦合机制研究
    HIV-1低病毒血症患者储存库活性与耐药突变评价体系的临床应用研究
    新型工程化广谱中和抗体清除HIV-1潜伏 感染细胞的功能和机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      陈军见
    • 依托单位:
    HIV-1与免疫应答致低病毒血症综合研究
    • 批准号:
      2025JJ80674
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      丁莉莎
    • 依托单位: